Kidney cancer affects over 80,000 Americans annually, with renal cell carcinoma as the dominant type. Benjamin R. Lee, MD, MBA, outlines current AUA guideline recommendations, including when to…
Dr. Allison Betof Warner from Stanford University joins Rahul Gosain, MD and Rohit Gosain, MD, on the Oncology Brothers podcast to discuss melanoma treatment. The conversation covers the…
NEW YORK (Reuters Health) – Hormone replacement therapy (HRT) with estrogen/progestin reduces the risk of colorectal cancer, but Israeli researchers have found that aspirin use and an active…
NEW YORK (Reuters Health) – “There is no strong evidence” that any significant subpopulation of breast cancer patients diagnosed in the 1980s and early 1990s was ever “cured,”…
NEW YORK (Reuters Health) – Patients with high-risk esophageal varices treated with the beta-blocker carvedilol had lower rates of first bleeding episodes than patients treated with variceal band…
The diagnosis of prostate cancer can be a confusing and scary time for many men. Ken Burger discusses his process of learning to adapt and deal with the…
NEW YORK (Reuters Health) – Laparoscopic surgery is as efficient as open surgery for rectal cancer, according to results of a randomized trial. Dr. Juan Lujan and colleagues…
NEW YORK (Reuters Health) – The median survival of patients with peritoneal breast cancer metastasis is “surprisingly poor,” with only a small minority surviving longer than 6 months,…
NEW YORK (Reuters Health) – Because of their ability to prevent, reduce, and delay skeletal complications with multiple myeloma, bisphosphonates are an essential component of treatment for this…
NEW YORK (Reuters Health) – Women treated for grade 1 breast cancer have a low risk of locoregional recurrence and contralateral breast cancer, results of a study indicate.…
NEW YORK (Reuters Health) – Disease-free survival with breast cancer is not improved by adding tamoxifen therapy either before or after treatment with letrozole, according to a report…
Miguel Materin, MD, Assistant Professor of Ophthalmology, Director of Ocular Oncology Section Yale University School of Medicine, describes uveal melanoma, a rare cancer but the most common cause…
